# OTEZLA
> **NDA210745** · New Drug Application · Sponsor: AMGEN INC · Approved 2025-08-29
## Drug
- **FDA Application Number:** NDA210745
- **Application type:** New Drug Application
- **Brand name:** OTEZLA
- **Generic name:** Apremilast
- **Active ingredients:** APREMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMGEN INC
- **First approval:** 2025-08-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210745)
---
*AI Analytics · CC0 1.0*